(19)
(11) EP 2 282 767 A2

(12)

(88) Date of publication A3:
07.01.2010

(43) Date of publication:
16.02.2011 Bulletin 2011/07

(21) Application number: 09747101.5

(22) Date of filing: 15.04.2009
(51) International Patent Classification (IPC): 
A61K 38/48(2006.01)
(86) International application number:
PCT/US2009/040691
(87) International publication number:
WO 2009/140015 (19.11.2009 Gazette 2009/47)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 16.04.2008 US 124568 P

(71) Applicant: Bayer HealthCare LLC
Tarrytown, NY 10591 (US)

(72) Inventors:
  • BROOKS, Alan, R.
    Clayton, CA 94517 (US)
  • MURPHY, John, E.
    Berkeley, CA 94707 (US)
  • SETO, Marian
    Orinda, CA 94563 (US)
  • JIANG, Xiaoqiao
    Concord, CA 94518 (US)
  • KIEWLICH, David
    Alameda, CA 94501 (US)
  • PATEL, Chandra
    Foster City, CA 94404 (US)

(74) Representative: Burkert, Frank 
Bayer HealthCare AG LP-PL, Q18
51368 Leverkusen
51368 Leverkusen (DE)

   


(54) SITE-DIRECTED MODIFICATION OF FACTOR IX